Last Updated: July 2, 2026

PROCAINAMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Procainamide patents expire, and what generic alternatives are available?

Procainamide is a drug marketed by Ani Pharms, Ascot, Ivax Sub Teva Pharms, Lannett, Lederle, Roxane, Vangard, Watson Labs, Abraxis Pharm, Caplin, Gland, Hikma, Hospira, Intl Medication, Nexus, Pharmafair, Smith And Nephew, Solopak, Warner Chilcott, West-ward Pharms Int, Inwood Labs, and Sandoz. and is included in sixty NDAs.

The generic ingredient in PROCAINAMIDE is procainamide hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Procainamide

A generic version of PROCAINAMIDE was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.

  Start Trial

AI Deep Research
Ask!
Questions you can ask:
  • What is the 5 year forecast for PROCAINAMIDE?
  • What are the global sales for PROCAINAMIDE?
  • What is Average Wholesale Price for PROCAINAMIDE?
Summary for PROCAINAMIDE
US Patents:0
Applicants:22
NDAs:60
Drug Prices: Drug price information for PROCAINAMIDE
DailyMed Link:PROCAINAMIDE at DailyMed
Drug patent expirations by year for PROCAINAMIDE
Drug Prices for PROCAINAMIDE

See drug prices for PROCAINAMIDE

US Patents and Regulatory Information for PROCAINAMIDE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmafair PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 088824-001 Nov 20, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Gland PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 218135-002 Jul 22, 2024 AP RX No Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 087080-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sandoz PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 089284-001 Jun 23, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Solopak PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 088532-001 Mar 4, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
West-ward Pharms Int PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride INJECTABLE;INJECTION 089030-001 Apr 17, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ani Pharms PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 088974-001 Jul 22, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links